Barclays sets USD 165.00 target for Becton Dickinson stock

Published on 10/15/2026 at 21:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BDX reports fourth-quarter results on November 5, 2026. Becton Dickinson stock costs EUR 172.30 on October 15, 2026 at 9:01 p.m. CEST at Lang & Schwarz.

Targets dates and valuation

MarketBeat reported a new Becton Dickinson 52-week high of USD 193.23 on October 15, 2026.
Becton Dickinson is scheduled to report fourth-quarter results on November 5, 2026.
Becton Dickinson stock costs EUR 172.30 at Lang & Schwarz on October 15, 2026 at 9:01 p.m. CEST.
The company has a market capitalization of USD 52.6 billion as of October 15, 2026.

Steriler Reinraum mit Mitarbeitern an der Produktionslinie für Medizinprodukte — Becton Dickinson betreibt moderne Reinraum Fertigungsanlagen für Medizinprodukte weltweit, ISIN US0718131099 NYSE, Illustration mit AI erstellt.

Becton Dickinson reached a new 52-week high of USD 193.23 on October 15, 2026, according to MarketBeat. The move keeps the medical technology company close to the top of its recent trading range. Becton Dickinson was at EUR 172.30 at Lang & Schwarz on October 15, 2026 at 9:01 p.m. CEST.

November 5 results date

Becton Dickinson is scheduled to report its fourth-quarter 2026 results before the market opens on November 5, 2026, according to Simply Wall St. That date gives investors the next scheduled checkpoint for revenue, earnings and the company outlook.

Range and recent performance

The primary-market quote was USD 192.94 on the NYSE at 3:02 p.m. ET on October 15, 2026. Becton Dickinson's 52-week range was USD 127.59 to USD 193.76, putting the latest US quote USD 0.82 below the high. The range spans USD 66.17, a substantial gap between the year's low and high.

MarketBeat reported quarterly revenue of USD 4.98 billion and earnings per share of USD 3.23 for the quarter reported on August 6, 2026. Revenue was above the USD 4.89 billion consensus estimate, while earnings per share exceeded the USD 3.14 estimate. For fiscal year 2026, the company set earnings-per-share guidance at USD 12.62 to USD 12.72.

Valuation and cash returns

Becton Dickinson had a market capitalization of USD 52.6 billion, a price-to-earnings ratio of 58.08 and a dividend yield of 2.00 percent on October 15, 2026. The company paid a quarterly dividend of USD 1.05 per share on September 30, 2026. The scheduled November report will show whether the latest valuation is supported by the next set of operating figures.

Comparison with peers

Becton Dickinson (NYSE, USD): price-to-earnings ratio 58.08, market capitalization USD 52.6 billion

Medtronic (NYSE, USD): plus 1.48 percent, price-to-earnings ratio 23.55, market capitalization USD 122.3 billion

Abbott Laboratories (NYSE, USD): plus 2.29 percent, price-to-earnings ratio 33.68, market capitalization USD 181.1 billion

Price and investor perspective

The 52-week high puts the latest US quote close to the upper end of the annual range, while the next reporting date supplies the next concrete test for earnings and guidance. The euro quote from Lang & Schwarz was EUR 172.30 on October 15, 2026 at 9:01 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Becton Dickinson stock.